12:00 AM
Sep 10, 2012
 |  BC Week In Review  |  Company News  |  Management Tracks

BioMarin management update

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Novato, Calif.
Business: Endocrine/Metabolic, Autoimmune, Cancer

Read the full 35 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >